Pharmaceuticals company Ajanta Pharma announced Q1FY24 results: Revenue from operations at Rs 1,021 crore in Q1FY24 against Rs 951 crore in Q1FY23; up 7% YoY EBITDA at Rs 271 crore in Q1FY24 against Rs 222 crore in Q1FY23; up 22%; EBITDA at 26% YoY Profit after tax at Rs 208 crore in Q1FY24 against Rs 175 crore in Q1FY23; up 19%; PAT at 20% YoY R&D; expenses were Rs 55 crore, 5% of revenue. Board of Directors has approved 1st interim dividend of Rs 315 crore for the year FY24. It translated into Rs 25 per share (1250%) for each Rs 2 face value share. This total dividend of Rs 25 per share includes a regular dividend of Rs 10 per share, and an additional Rs 15 per share, distributed as a special dividend on the commemoration of 50 years of the momentous journey of the Company. Result PDF